EMA (EU)
EVENT
Fifth European Medicines Agency (EMA) - Vaccines Europe bilateral meeting
Published: 10/26/2026Detected: 10/17/2026
Summary preview
Facilitates an EMA–Vaccines Europe bilateral exchange to align on topics of common interest within the European vaccines regulatory landscape.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountimmunology
infectious_disease
#EMA
#vaccines
#Vaccines Europe
#bilateral meeting
#industry stakeholder engagement
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 202610/26/2026
- Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system10/26/2026
- Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 202610/26/2026
- European platform for regulatory science research meeting: October 202610/22/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/22/2026